Will Pharma Firms Bear Cost Of UK Govt’s Latest No-Deal Brexit Supply Plans?
Executive Summary
Life science companies are uneasy over the government’s latest proposals for emergency medical supplies to the UK if the country leaves the EU without a deal.
You may also be interested in...
Firms Still In Dark Over No-Deal Brexit Supply Routes
Life science companies need more information on plans for alternative medicine supply routes if the UK leaves the EU without a deal, according to the BioIndustry Association, which says the release of the Operation Yellowhammer document shows the “significant impact” such an outcome would have on the sector.
UK Parliament Suspension Could Make No-Deal Brexit More Likely
Critics of the government's decision to suspend parliament for five weeks say it will make a no-deal Brexit more likely – a prospect that the life sciences industry is particularly worried about.
UK Parliament Suspension Could Make No-Deal Brexit More Likely
Critics of the government's decision to suspend parliament for five weeks say it will make a no-deal Brexit more likely – a prospect that the life sciences industry is particularly worried about.